| Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ... Archives of internal medicine 170 (16), 1433-1441, 2010 | 1075 | 2010 |
| Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective … R Sørensen, ML Hansen, SZ Abildstrom, A Hvelplund, C Andersson, ... The Lancet 374 (9706), 1967-1974, 2009 | 719 | 2009 |
| Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries SD Kristensen, KG Laut, J Fajadet, Z Kaifoszova, P Kala, C Di Mario, ... European heart journal 35 (29), 1957-1970, 2014 | 501 | 2014 |
| Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ... Archives of internal medicine 169 (2), 141-149, 2009 | 381 | 2009 |
| Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study M Charlot, O Ahlehoff, ML Norgaard, CH Jørgensen, R Sørensen, ... Annals of internal medicine 153 (6), 378-386, 2010 | 344 | 2010 |
| Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study M Lamberts, GH Gislason, GYH Lip, JF Lassen, JB Olesen, AP Mikkelsen, ... Circulation 129 (15), 1577-1585, 2014 | 318 | 2014 |
| Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial DJ Hausenloy, RK Kharbanda, UK Møller, M Ramlall, J Aarøe, R Butler, ... The Lancet 394 (10207), 1415-1424, 2019 | 316 | 2019 |
| Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study D Erlinge, A Maehara, O Ben-Yehuda, HE Bøtker, M Maeng, ... The Lancet 397 (10278), 985-995, 2021 | 302 | 2021 |
| Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial L Räber, Y Ueki, T Otsuka, S Losdat, JD Häner, J Lonborg, G Fahrni, ... Jama 327 (18), 1771-1781, 2022 | 292 | 2022 |
| Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations F Folke, FK Lippert, SL Nielsen, GH Gislason, ML Hansen, TK Schramm, ... Circulation 120 (6), 510-517, 2009 | 267 | 2009 |
| Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals EL Fosbøl, F Folke, S Jacobsen, JN Rasmussen, R Sørensen, ... Circulation: Cardiovascular Quality and Outcomes 3 (4), 395-405, 2010 | 252 | 2010 |
| Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ... Circulation 116 (7), 737-744, 2007 | 242 | 2007 |
| Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study R Sørensen, G Gislason, C Torp-Pedersen, JB Olesen, EL Fosbøl, ... BMJ open 3 (5), e002758, 2013 | 228 | 2013 |
| Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study EL Fosbøl, GH Gislason, S Jacobsen, F Folke, ML Hansen, TK Schramm, ... Clinical Pharmacology & Therapeutics 85 (2), 190-197, 2009 | 223 | 2009 |
| Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011–2013 JB Olesen, R Sørensen, ML Hansen, M Lamberts, P Weeke, ... EP Europace 17 (2), 187-193, 2014 | 208 | 2014 |
| Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction AMS Olsen, GH Gislason, P McGettigan, E Fosbøl, R Sørensen, ... Jama 313 (8), 805-814, 2015 | 207 | 2015 |
| The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people EL Fosbøl, GH Gislason, S Jacobsen, SZ Abildstrom, ML Hansen, ... Pharmacoepidemiology and drug safety 17 (8), 822-833, 2008 | 168 | 2008 |
| Applied mediation analyses: a review and tutorial T Lange, KW Hansen, R Sørensen, S Galatius Epidemiology and health 39, 2017 | 111 | 2017 |
| Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients J Eklöf, R Sørensen, TS Ingebrigtsen, P Sivapalan, I Achir, JB Boel, ... Clinical Microbiology and Infection 26 (2), 227-234, 2020 | 108 | 2020 |
| Field Triage Reduces Treatment Delay and Improves Long-Term Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction Treated With … SH Pedersen, S Galatius, PR Hansen, R Mogelvang, SZ Abildstrom, ... Journal of the American College of Cardiology 54 (24), 2296-2302, 2009 | 105 | 2009 |
Gunnar GislasonProfessor of Cardiology, Copenhagen University Hospital Herlev and Gentofte在 regionh.dk 的电子邮件经过验证
